Trial Profile
Clinical Trials Insight: 700056498
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 27 May 2010
Price :
$35
*
At a glance
- Drugs Actoxumab/bezlotoxumab (Primary)
- Indications Clostridium difficile infections; Diarrhoea
- Focus Therapeutic Use
- 27 May 2010 New trial record